Study Design, Setting, and Population
A retrospective cohort study was performed among adult encounters (age ≥18 years) with suspected infection. The primary cohort was all hospital encounters from 2010 to 2012 at 12 community and academic hospitals in the UPMC health care system in southwestern Pennsylvania. The cohort included all medical and surgical encounters in the emergency department, hospital ward, and intensive care unit (ICU). We created a random split sample (50/50) from the UPMC cohort, the derivation cohort for developing new criteria, and the validation cohort for assessment of new and existing criteria.
We also studied 4 external data sets: (1) all inpatient encounters at 20 KPNC hospitals from 2009 to 2013; (2) all encounters in 130 hospitals in the United States' VA system from 2008 to 2010; (3) all nontrauma, nonarrest emergency medical services records from 5 advanced life support agencies from 2009-2010 transported to 14 hospitals with community infection in King County, Washington (KCEMS) 6 ; and (4) all patients from 2011-2012 at 1 German hospital enrolled with hospital-acquired infection in the ALERTS prospective cohort study. 7 These cohorts were selected because they included patient encounters from different phases of acute care (out of hospital, emergency department, hospital ward) and countries (United States and Germany) with different types of infection (community and nosocomial). The UPMC, KPNC, and VA data were obtained from the electronic health records (EHRs) of the respective health systems; KCEMS data were obtained from the administrative out-of-hospital record; and ALERTS data were collected prospectively by research coordinators.
Defining a Cohort With Suspected Infection
For EHR data (UPMC, KPNC, and VA), the first episode of suspected infection was identified as the combination of antibiotics (oral or parenteral) and body fluid cultures (blood, urine, cerebrospinal fluid, etc). We required the combination of culture and antibiotic start time to occur within a specific time epoch. If the antibiotic was given first, the culture sampling must have been obtained within 24 hours. If the culture sampling was first, the antibiotic must have been ordered within 72 hours. The "onset" of infection was defined as the time at which the first of these 2 events occurred (eAppendix in the Supplement). For non-EHR data in ALERTS, patients were included who met US Centers for Disease Control and Prevention definitions or clinical criteria for hospital-acquired infection more than 48 hours after admission as documented by prospective screening. 7 For non-EHR data in KCEMS, administrative claims identified infection present on admission (Angus implementation of infection using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes). 6 
Determining Clinical Criteria for Sepsis Using Existing Measures
In UPMC derivation and validation data, indicators were generated for each component of the systemic inflammatory response syndrome (SIRS) criteria 4 ; the Sequential [Sepsisrelated] Organ Failure Assessment (SOFA) score 8 ; and the Logistic Organ Dysfunction System (LODS) score, 9 a weighted organ dysfunction score ( Table 1) . We used a modified version of the LODS score that did not contain urine output (because of poor accuracy in recording on hospital ward encounters), prothrombin, or urea levels. The maximum SIRS criteria, SOFA score, and modified LODS score were calculated for the time window from 48 hours before to 24 hours after the onset of infection, as well as on each calendar day. This window was used for candidate criteria because organ dysfunction in sepsis may occur prior to, near the moment of, or after infection is recognized by clinicians or when a patient presents for care. Moreover, the clinical documentation, reporting of laboratory values in EHRs, and trajectory of organ dysfunction are heterogeneous across encounters and health systems. In a post hoc analysis requested by the task force, a change in SOFA score was calculated of 2 points or more from up to 48 hours before to up to 24 hours after the onset of infection.
Deriving Novel Clinical Criteria for Sepsis
In the derivation cohort (UPMC), new, simple criteria were developed according to the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) recommendations. 10 This entailed 2 steps: (1) assessing candidate variable quality and frequency of missing data and (2) developing a parsimonious model and simple point score. 3, 8, 11 Because of the subjective nature and complexity of variables in existing criteria, we sought a simple model that could easily be used by a clinician at the bedside.
Based on the assumption that hospital mortality would be far more common in encounters with infected patients who have sepsis than in those who do not, all continuous variables were dichotomized by defining their optimal cutoffs using the minimum 0/1 distance on the area under the receiver operating characteristic curve (AUROC) for in-hospital mortality. 12 Cutoffs were rounded to the nearest integer, and standard single-value imputation was used, with normal value substitution if variables were missing. The latter approach is standard in clinical risk scores 8, 13, 14 and mirrors how clinicians would use the score at the bedside. Multiple logistic regression was used with robust standard errors and forward selection of candidate variables using the Bayesian information criterion to develop the "quick SOFA" (qSOFA) model. The Bayesian information criterion is a likelihood-based stepwise approach that retains variables that improve the model's overall ability to predict the outcome of interest while incorporating a penalty for including too many variables. Favoring simplicity over accuracy, a point score of 1 was assigned to each variable in the final model, irrespective of the regression coefficients. Model calibration was assessed by comparing clinically relevant differences in observed vs expected outcomes, as the Hosmer-Lemeshow test may be significant due to large sample sizes. 15 
Assessments of Candidate Clinical Criteria
The test:retest or interrater reliability of individual elements was not assessed, in part because most elements have known reliability. However, the frequency of missing data was determined for each element because more common missing data for individual elements will potentially affect the reliability of integrated scores such as the SOFA score. Construct validity was determined by examining the agreement between different measures analogous to the multitrait-multimethod matrix approach of Campbell and Fiske, using the Cronbach α to measure agreement or commonality. 16, 17 Confidence intervals were generated with the bootstrap method (100 replications).
Criterion validity was assessed using the predictive validity of the candidate criteria with outcomes (primary outcome: in-hospital mortality; secondary outcome: in-hospital mortality or intensive care unit [ICU] length of stay ≥3 days). These outcomes are objective, easily measured across multiple hospitals in US/non-US cohorts, and are more likely to be present in encounters with patients with sepsis than those with uncomplicated infection. To measure predictive validity, a baseline risk model was created for in-hospital mortality based on preinfection criteria using multivariable logistic regression. The baseline model included age (as a fractional polynomial), sex, race/ ethnicity (black, white, or other), and the weighted Charlson comorbidity score (as fractional polynomial) as a measure of chronic comorbidities. 18, 19 Race/ethnicity was derived from UPMC registration system data using fixed categories consistent with the Centers for Medicare & Medicaid Services EHR meaningful use data set. 20 Race/ethnicity was included in the baseline model because of its described association with the incidence and outcomes of sepsis. 21 Encounters were then divided into deciles of baseline risk. Within each decile, the rate of in-hospital mortality ± ICU length of stay of 3 days or longer was determined comparing encounters with infection with 2 or more SIRS, SOFA, LODS, and qSOFA points vs encounters with less than 2 criteria of the same score (threshold of 2 points was determined a priori). Model discrimination was assessed with the AUROC for each outcome using the continuous score(s) alone, then added to the baseline risk model. Analyses were separately performed in ICU encounters and non-ICU encounters at the onset of infection. New, simple criteria in external data sets were assessed in both ICU and non-ICU encounters.
Because serum lactate is widely used as a screening tool in sepsis, 22 how its measurement would improve predictive validity of new criteria was assessed in post hoc analyses. Evaluation included qSOFA models that did and did not include serum lactate at thresholds of 2.0, 3.0, and 4.0 mmol/L (18, 27, and 36 mg/dL) and as a continuous variable. 23 Only KPNC data were used for these analyses because an ongoing quality improvement program promoting frequent serum lactate measurement across the health system minimized confounding by indication. 24 Several sensitivity analyses were performed to assess robustness of the findings. These included a variety of restrictions to the cohort, more rigorous definitions of suspected or presumed infection, alternative ways to measure clinical variables (such as altered mentation in the EHR), and multiple imputation analyses for missing data. There are many possible time windows for criteria around the onset of infection. A variety of windows differing from the primary analysis were tested, including (1) 3 hours before to 3 hours after; (2) 12 hours before to 12 hours after; and (3) restricting to only the 24 hours after the onset of infection. Detailed descriptions are in the Supplement.
All analyses were performed with STATA software, version 11.0 (Stata Corp). All tests of significance used a 2-sided P ≤ .05. We considered AUROCs to be poor at 0.6 to 0.7, adequate at 0.7 to 0.8, good at 0.8 to 0.9, and excellent at 0.9 or higher. 25 
Results

Cohorts and Encounter Characteristics
At 177 hospitals in 5 US and non-US data sets between 2008 and 2013 ( Table 2) , 4 885 558 encounters were studied. In the primary cohort of 1 309 025 records (UPMC derivation and validation; Figure 1 ), 148 907 encounters had suspected infection, most often presenting outside of the ICU (n = 133 139 [89%]). As shown in Table 3 , first infection was commonly suspected within 48 hours of admission (86%), most often presenting in the emergency department (44%) compared with the ward (33%) or ICU (11%), and mortality was low (4%). The , first suspected infections occurred outside the ICU (98%) with similar mortality (5%) and proportion identified within 48 hours of admission (81%). Serum lactate was measured in 57% of suspected infection encounters in KPNC hospitals compared with less than 10% in the other cohorts. In VA hospitals, encounters with suspected infection had similar mortality (6%) but were more likely to be first identified in the ICU (19%). A minority of first infection episodes occurred following surgery, and positive blood cultures were found in 5% to 19% of encounters. In the baseline risk model, using only demographics and comorbidities, there was a 10-fold variation for in-hospital mortality across deciles of baseline risk, ranging from 0.7% to 8% (eFigure 1 in the Supplement).
Frequency of Missing Data Among Clinical and Laboratory Variables
In the UPMC derivation cohort, SIRS criteria and selected laboratory tests in SOFA and LODS were variably measured in the EHR near the onset of infection (eFigure 2 in the Supplement). Tachycardia, tachypnea, and hypotension, although present in less than 50% of encounters, were the most common clinical abnormalities. Encounters in the ICU were more likely to have SIRS and SOFA variables measured and values were more likely to be abnormal. For encounters outside of the ICU, laboratory data were less available, with total bilirubin, ratio of PaO 2 to fraction of inspired oxygen, and platelet counts absent in 62%, 74%, and 15% of encounters, respectively. (Figure 3) . Encounters in the ICU with 2 or more vs less than 2 SIRS criteria were compared within decile of baseline risk and observed a 1-to 2-fold increased rate of hospital mortality compared with a 3-to 11-fold increase in mortality comparing those with 2 or more vs less than 2 SOFA points ( Figure 4 ). The fold change in the LODS score was even greater than that for SOFA. In the ICU, the predictive validity for hospital mortality using SOFA (AUROC = 0.74; 95% CI, 0.73-0.76) and LODS (AUROC = 0.75; 95% CI, 0.73-0.76; P = .20) were not statistically different but were statistically greater than that of SIRS (AUROC = 0.64; 95% CI, 0.62-0.66; P < .001 for either LODS or SOFA vs SIRS) ( Figure 3 and eFigure 4 and eTable 2 in the Supplement). Results for a change in SOFA of 2 points or more were significantly greater compared with SIRS (AUROC = 0.70; 95% CI, 0.68-0.71; P < .001 vs SIRS criteria). The SOFA score was 2 or more in 98% of decedents (95% CI, 97%-99%); among survivors, the SOFA score was less than 2 in 10% (95% CI, 10%-11%). These proportions were similar for a LODS threshold of 2 or 3 (eTable 3 in the Supplement). Among decedents, 2 or more SIRS criteria were present in 91% (95% CI, 89%-92%). Results were consistent for the combined outcome (eFigures 5 and 6 in the Supplement).
Performance of
Performance of Existing Criteria Outside the ICU in the UPMC Cohort
For encounters with suspected infection outside of the ICU (n = 66 522 [89% of cohort]), 20 130 (30%) had no SIRS criteria, 27 560 (41%) had no SOFA points, and 29 789 (45%) had no LODS points ( Figure 2 ). Agreement followed a pattern simi- teria had a 2-to 7-fold increase in the rate of in-hospital mortality compared with up to an 80-fold change for 2 or more vs less than 2 SOFA points. (9) Weighted Charlson comorbidity index, median (IQR) (2) Step-down unit 15 662 (11) Table 1 ). 29 Maximum score is determined from 48 hours before to 24 hours after onset of infection. d The SOFA score ranges from 0 to 24, where 0 to 4 points are assigned for 1 of 6 organ dysfunctions: hematologic, hepatic, respiratory, neurologic, cardiac, and renal. 8 A greater score corresponds to greater severity. Maximum score is determined from 48 hours before to 24 hours after onset of infection. e The LODS score, modified for available data, ranges from 0 to 22 points, wherein points are assigned with increasing severity to hematologic, hepatic, pulmonary, neurologic, cardiovascular, and renal dysfunction. 9 Maximum score is determined from 48 hours before to 24 hours after onset of infection. Organ Function Assessment. The x-axis is the score range, with LODS truncated at 14 points (of 22 points) and SOFA truncated at 16 points (of 24 points) for illustration.
Performance of New, Simple Criteria
The final qSOFA model included Glasgow Coma Scale (GCS) score of 13 or less, systolic blood pressure of 100 mm Hg or less, and respiratory rate of 22/min or more (1 point each; score range, 0-3) ( Table 4 ). Most encounters with infection (73%-90%) had less than 2 qSOFA points, and mortality ranged from 1% to 24% over the score range (eFigure 7 in the Supplement). Calibration plots showed similar observed vs expected proportion of deaths across qSOFA scores (eFigure 8 in the Supplement). The qSOFA agreed reasonably well with both SOFA (α = 0.73; 95% CI, 0.73-0.74) and LODS (α = 0.79; 95% CI, 0.78-0.79) and, unlike SOFA and LODS, also agreed more with SIRS (α = 0.69; 95% CI, 0.68-0.69) ( Figure 3 ). The 24% of encounters with infection with 2 or 3 qSOFA points accounted for 70% of deaths, 70% of deaths or ICU stays of 3 days or longer.
In the ICU, the predictive validity for hospital mortality of qSOFA above baseline risk (AUROC = 0.66; 95% CI, 0.64-0.68) was statistically greater than SIRS criteria (P = .01) but significantly less than SOFA (P < .001) (Figure 3 and eFigure 4 and eTable 2 in the Supplement). Outside of the ICU, there was a 3-to 14-fold increase in the rate of hospital mortality across the entire range of baseline risk comparing those with 2 or more vs less than 2 qSOFA points ( Figure 4 ). The predictive validity of qSOFA was good for in-hospital mortality (AUROC = 0.81; 95% CI, 0.80-0.82), was not statistically different from LODS (P = .77) and was statistically greater than SOFA or change in SOFA score (P < .001 for both) (Figure 3 , Figure 4 , and eFigure 4 and eTable 2 in the Supplement). Seventy percent (95% CI, 69%-72%) of decedents had 2 or more qSOFA points and 78% (95% CI, 78%-79%) of survivors had less than 2 qSOFA points (eTable 3 in the Supplement). Results were consistent for the combined outcome (eFigures 5 and 6 in the Supplement).
Among encounters with 2 or more qSOFA points, 75% also had 2 or more SOFA points (eFigure 9 in the Supplement). This proportion was greater among decedents (89%) and ICU encounters (94%) and increased as the time window for evaluation was extended to 48 hours (90%) and 72 hours (92%) after the onset of infection.
External Data Sets
The qSOFA was tested in 4 external data sets comprising 706 399 patient encounters at 165 hospitals in out-ofhospital (n = 6508), non-ICU (n = 619 137), and ICU (n = 80 595) .001) . However, the clinical relevance was small as the rates of in-hospital mortality comparing encounters with 2 or more vs less than 2 points across deciles of risk were numerically similar whether or not serum lactate was included in qSOFA (eFigure 10B in the Supplement). Among encounters with 1 qSOFA point but also a serum lactate level of 2.0 mmol/L or more, in-hospital mortality was higher than that for encounters with serum lactate levels of less than 2.0 mmol/L across the range of baseline risk. The rate of in-hospital mortality was numerically similar to that for encounters with 2 qSOFA points using the model without serum lactate (eFigure 11 in the Supplement). Because serum lactate levels are widely used for screening at many centers, the distribution of qSOFA scores over strata of serum lactate level was investigated. The qSOFA consistently identified higherrisk encounters even at varying serum lactate levels (eFigure 12 in the Supplement). Interpretive example: The x-axis divides the cohort into deciles of baseline risk, determined by age, sex, comorbidities, and race/ethnicity. For a young woman with no comorbidities (panel A, decile 2) admitted to the ICU with pneumonia, her chance of dying in the hospital is 10-fold greater if she has 3 SOFA points compared with 1 SOFA point. On the other hand, she has only a small increase in the chance of dying if she has 3 SIRS criteria compared with 1 SIRS criterion. For an older woman with chronic obstructive pulmonary disease admitted to the ward with pneumonia (panel B, decile 6), her chance of dying in the hospital is 7-fold higher if she has 3 qSOFA points compared with 1 qSOFA point. On the other hand, she has only a 3-fold increase in odds of dying if she has 3 SIRS criteria compared with 1 SIRS criterion.
Time Windows for Measuring qSOFA Variables
When qSOFA variables were measured in the time window from 3 hours before/after or 12 hours before/after the onset of infection in KPNC data (eTable 4 in the Supplement), results were not significantly different from the original model (P = .13 for 3 hours and P = .74 for 12 hours). When qSOFA variables were restricted to only the 24-hour period after the onset of infection, the predictive validity for in-hospital mortality was significantly greater (AUROC = 0.83; 95% CI, 0.83-0.84; P < .001) compared with the primary model.
Additional sensitivity analyses are shown in eTable 4 in the Supplement. The predictive validity of qSOFA was not significantly different when using more simple measures, such as any altered mentation (GCS score <15 [P = .56] compared with the model with GCS score ≤13). The predictive validity was also not significantly different when performed after multiple imputation for missing data and in a variety of a priori subgroups.
Discussion
The Third International Consensus Definitions Task Force defined sepsis as a "life-threatening organ dysfunction due to a dysregulated host response to infection." 5 In the absence of a gold-standard test for sepsis, several domains of validity and usefulness were used to assess potential clinical criteria to operationalize this definition. Among encounters with suspected infection in the ICU (Figure 3 ), SOFA and LODS had statistically greater predictive validity compared with SIRS criteria. Outside of the ICU, a simple model (qSOFA) of altered menta- tion, low systolic blood pressure, and elevated respiratory rate had statistically greater predictive validity than the SOFA score ( Figure 3 ). The predictive validity of qSOFA was robust to evaluation under varied measurement conditions, in academic and community hospitals, in international locations of care, for community and hospital-acquired infections, and after multiple imputation for missing data. It was, however, statistically inferior compared with SOFA for encounters in the ICU and has a statistically lower content validity as a measure of multiorgan dysfunction. Thus, the task force recommended use of a SOFA score of 2 points or more in encounters with infection as criteria for sepsis and use of qSOFA in non-ICU settings to consider the possibility of sepsis.
Criteria Outside of the ICU
For infected patients outside of the ICU, there is an increasing focus on early recognition of sepsis. Potential criteria for organ dysfunction like SOFA or LODS required clinical and laboratory variables that may be missing and difficult to obtain in a timely manner. These characteristics may increase measurement burden for clinicians. In comparison, a simple model (qSOFA) uses 3 clinical variables, has no laboratory tests, and has a predictive validity outside of the ICU that is statistically greater than the SOFA score (P < .001). The qSOFA and SOFA scores also had acceptable agreement in the majority of encounters. However, 3 potentially controversial issues are worth noting. First, qSOFA was derived and tested among patient encounters in which infection was already suspected. The qSOFA is not an alert that alone will differentiate patients with infection from those without infection. However, at least in many US and European hospital settings, infection is usually suspected promptly, as evidenced by rapid initiation of antibiotics. 26, 27 Second, mental status is assessed variably in different settings, which may affect the performance of the qSOFA. Although the qSOFA appeared robust in sensitivity analyses to alternative GCS cut points, further work is needed to clarify its clinical usefulness. In particular, the model evaluated only whether mental status was abnormal, not whether it had changed from baseline, which is extremely difficult to operationalize and validate, both in the EHR and as part of routine charting. An alternative to the GCS (eg, Laboratory and Acute Physiology Score, version 2, in KPNC encounters) 28 found similar results.
Third, serum lactate levels, which have been proposed as a screening tool for sepsis or septic shock, were not retained in the qSOFA during model construction. One reason may be because serum lactate levels were not measured commonly in the UPMC data set. When serum lactate levels were added to qSOFA post hoc in the KPNC health system data set, in which measurement of lactate levels was common, the predictive validity was statistically increased but with little difference in how encounters were classified. This analysis assessed only how serum lactate levels at different thresholds contributed above and beyond the qSOFA model. However, among intermediaterisk encounters (qSOFA score = 1), the addition of a serum lactate level of 2.0 mmol/L (18 mg/dL) or higher identified those with a risk profile similar to those with 2 qSOFA points. Thus, areas for further inquiry include whether serum lactate lev-els could be used for patients with borderline qSOFA values or as a substitute for individual qSOFA variables (particularly mental status, given the inherent problems discussed above), especially in health systems in which lactate levels are reliably measured at low cost and in a timely manner.
Criteria in the ICU
Among ICU encounters, the diagnosis of sepsis may be challenging because of preexisting organ dysfunction, treatment prior to admission, and concurrent organ support. In this study, as others have reported in a distinct geographic region and health care system, 29 traditional tools such as the SIRS criteria have poor predictive validity among patients who are infected. Yet in our study, SOFA and LODS scores had superior predictive validity in the ICU and greater agreement, perhaps because more variables were likely to be measured, abnormal, and independent of ongoing interventions. These results are consistent with prior studies of SOFA and LODS in the ICU. 30, 31 On average, only 2 of 100 infected decedents in the ICU had a SOFA or LODS score of less than 2. The qSOFA score had statistically worse predictive validity in the ICU, likely related to the confounding effects of ongoing organ support (eg, mechanical ventilation, vasopressors).
Advances Using EHRs
The data from these analyses provided the Third International Consensus Task Force with evidence about clinical criteria for sepsis using EHRs from 3 large health systems with both academic and community hospitals. More than 60% of US nonfederal, acute care hospitals (and all US federal hospitals) now use advanced EHRs. Adoption of EHRs has increased 8-fold since 2009 in the United States and will continue to increase. 32 The EHR may present hospitals with an opportunity to rapidly validate criteria for patients likely to have sepsis, to test prompts or alerts among infected patients with specific EHR signatures suggestive of sepsis, and to build platforms for automated surveillance. 33 In addition, criteria such as in the qSOFA can be measured quickly and easily and assessed repeatedly over time in patients at risk of sepsis, perhaps even in developing countries without EHRs.
Limitations
This investigation has several limitations. First, we studied only patients in whom infection was already suspected or documented. We did not address how to diagnose infection among those in whom life-threatening organ dysfunction was the initial presentation. Therefore, these data alone do not mandate that hospitalized patients with SOFA or qSOFA points be evaluated for the presence of infection.
Second, we chose to develop simple criteria that clinicians could quickly use at the bedside, balancing timeliness and content validity with greater criterion validity. We acknowledge that predictive validity would be improved with more complex models that include interaction terms or serial measurements over time. 3, 34, 35 We tested how the change in SOFA score over time would perform, and although similar to the maximum SOFA score, the optimal time windows over which change should be measured are not known.
Third, no organ dysfunction measurements evaluated in this study distinguish between chronic and acute organ dysfunction, assess whether the organ dysfunction has an explanation other than infection, or attribute dysfunction specifically to a dysregulated host response. For example, a patient with dementia with an abnormal GCS score at baseline will always have 1 qSOFA point but may not be as likely to have sepsis as a patient with a normal baseline sensorium. As such, we illustrated the predictive validity of various criteria across a full range of underlying risk determined from comorbidity and demographics.
Fourth, we chose 2 outcomes associated more commonly with sepsis than with uncomplicated infection. These outcomes have high content validity and were generalizable across data sets, but there are certainly alternative choices. 36 Fifth, we compared predictive validity with tests of inference that may be sensitive to sample size. We found that statistically significant differences in AUROC were often present, yet these resulted in differences in classification with debatable clinical relevance. We reconciled these data by reporting the fold change in outcome comparing encounters of different scores to provide more clinical context.
Sixth, the acute, life-threatening organ dysfunction in sepsis may also occur at different times in different patients (before, during, or after infection is recognized). 37 Results were unchanged over a variety of time windows, including both long (72-hour) and short (6-hour) windows around the onset of infection. Prospective validation in other cohorts, assessment in low-to middle-income countries, repeated measurement, and the contribution of individual qSOFA elements to predictive validity are important future directions.
Conclusions
Among ICU encounters with suspected infection, the predictive validity for in-hospital mortality of SOFA was not significantly different than the more complex LODS but was statistically greater than SIRS and qSOFA, supporting its use in clinical criteria for sepsis. Among encounters with suspected infection outside of the ICU, the predictive validity for inhospital mortality of qSOFA was statistically greater than SOFA and SIRS, supporting its use as a prompt to consider possible sepsis.
